Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
24.32 USD | -2.78% |
|
+0.63% | +205.45% |
May. 31 | Jasper Therapeutics, Inc. to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI Congress 2024 | CI |
May. 20 | Transcript : Jasper Therapeutics, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+205.45% | 377M | |
+51.53% | 791B | |
+41.20% | 630B | |
+17.78% | 328B | |
+9.75% | 298B | |
+17.25% | 246B | |
+0.33% | 225B | |
+9.83% | 218B | |
+3.43% | 160B | |
-5.44% | 156B |
- Stock Market
- Equities
- JSPR Stock
- News Jasper Therapeutics, Inc.
- Jasper Therapeutics Names New CEO; Shares Climb